Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Boehringer Ingelheim
Medtronic
Dow
Baxter

Last Updated: May 28, 2022

CLINICAL TRIALS PROFILE FOR TAMSULOSIN HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

505(b)(2) Clinical Trials for Tamsulosin Hydrochloride

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT01726270 ↗ An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms Completed Boehringer Ingelheim Phase 2 2012-11-01 Multicenter trial conducted in Pharmacy retail centers
OTC NCT02573311 ↗ Actual Use Study of Tamsulosin in Men Completed Boehringer Ingelheim Phase 3 2015-09-23 An actual use study to assess how men who respond to advertisements about urinary symptoms use tamsulosin in a simulated Over the Counter (OTC) setting including following "stop use and ask a doctor if" and "ask a doctor before use" statements and if they take the medication according to the label instructions, also assess any reported adverse events during simulated OTC use.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for Tamsulosin Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00090103 ↗ Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment Completed GlaxoSmithKline Phase 3 2003-11-01 This study will investigate the efficacy and safety of treatment with dutasteride and tamsulosin, administered once daily for 4 years, alone and in combination, on the improvement of symptoms and clinical outcome in men with moderate to severe symptomatic Benign Prostatic Hyperplasia (BPH). Study visits are every 3 months for up to 4 years (18 clinic visits). Transrectal ultrasound (TRUS) is done annually.
NCT00147654 ↗ Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction Completed Pfizer Phase 4 2004-11-01 The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).
NCT00147654 ↗ Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction Completed Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Phase 4 2004-11-01 The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).
NCT00151567 ↗ Evaluation of Tamsulosin in the Treatment of Ureteral Stones Completed Ministry of Health, France Phase 3 2002-02-01 Ureteral stones have an important place in daily urological practice, usually causing acute episodes of ureteral colic by obstructing the urinary tract. The aim of the study is to evaluate whether repeated administration of tamsulosin, a drug routinely used in the treatment of lower urinary tract symptoms, could lower the delay of elimination of the stone in patients with pelvis ureterolithiasis.
NCT00151567 ↗ Evaluation of Tamsulosin in the Treatment of Ureteral Stones Completed Yamanouchi Phase 3 2002-02-01 Ureteral stones have an important place in daily urological practice, usually causing acute episodes of ureteral colic by obstructing the urinary tract. The aim of the study is to evaluate whether repeated administration of tamsulosin, a drug routinely used in the treatment of lower urinary tract symptoms, could lower the delay of elimination of the stone in patients with pelvis ureterolithiasis.
NCT00151567 ↗ Evaluation of Tamsulosin in the Treatment of Ureteral Stones Completed Rennes University Hospital Phase 3 2002-02-01 Ureteral stones have an important place in daily urological practice, usually causing acute episodes of ureteral colic by obstructing the urinary tract. The aim of the study is to evaluate whether repeated administration of tamsulosin, a drug routinely used in the treatment of lower urinary tract symptoms, could lower the delay of elimination of the stone in patients with pelvis ureterolithiasis.
NCT00201630 ↗ Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy Unknown status Sanofi Phase 3 2005-09-01 To asess the efficacy of Uroxatrol, an alpha blocker in men undergoing prostate brachytherapy to treat prostate cancer, and whether the use of Uroxatrol in advance of the brachytherapy is better or not than starting it on the day of surgery.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Tamsulosin Hydrochloride

Condition Name

Condition Name for Tamsulosin Hydrochloride
Intervention Trials
Benign Prostatic Hyperplasia 31
Prostatic Hyperplasia 30
Lower Urinary Tract Symptoms 13
Urinary Retention 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Tamsulosin Hydrochloride
Intervention Trials
Prostatic Hyperplasia 72
Hyperplasia 70
Lower Urinary Tract Symptoms 25
Urinary Retention 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Tamsulosin Hydrochloride

Trials by Country

Trials by Country for Tamsulosin Hydrochloride
Location Trials
United States 216
Germany 42
Korea, Republic of 33
Italy 28
United Kingdom 25
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Tamsulosin Hydrochloride
Location Trials
California 12
New York 11
Texas 10
Alabama 10
Ohio 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Tamsulosin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Tamsulosin Hydrochloride
Clinical Trial Phase Trials
Phase 4 50
Phase 3 39
Phase 2/Phase 3 2
[disabled in preview] 82
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Tamsulosin Hydrochloride
Clinical Trial Phase Trials
Completed 111
Unknown status 28
Recruiting 15
[disabled in preview] 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Tamsulosin Hydrochloride

Sponsor Name

Sponsor Name for Tamsulosin Hydrochloride
Sponsor Trials
Boehringer Ingelheim 20
GlaxoSmithKline 20
Astellas Pharma Inc 13
[disabled in preview] 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Tamsulosin Hydrochloride
Sponsor Trials
Other 115
Industry 109
NIH 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKinsey
Dow
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.